Gene Therapy: Treating disease by repairing genes. / (Record no. 6531)

000 -LEADER
fixed length control field 01914nam a22001577a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 180212b xxu||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0816049483
050 ## - LIBRARY OF CONGRESS CALL NUMBER
Classification number RB155.8.P36
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Panno, Joseph.
245 ## - TITLE STATEMENT
Title Gene Therapy: Treating disease by repairing genes. /
Statement of responsibility, etc. Joseph Pano.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. New York:
Name of publisher, distributor, etc. Fact On File,
Date of publication, distribution, etc. 2005.
300 ## - PHYSICAL DESCRIPTION
Extent xvii, 172p.:
Other physical details ills.;
Dimensions 23cm.
500 ## - GENERAL NOTE
General note Includes Index.
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Contents: Genetic Disorders: Immune Deficiencies -- Breast Cancer -- Colon Cancer -- Melanoma -- Cystic Fibrosis -- Hemophilia -- Liver Disease -- Cardiovascular Disease -- Muscular Dystrophy -- Alzheimer's Disease -- Parkinson's Disease -- Huntington's Disease -- Viruses: The Cornerstone of Gene Therapy: Viruses are Living Crystals Viral Genomes May be RNA or DNA -- Viruses Evolved from Plasmids -- Viruses know how to Infect Cells -- The Viruses as a Gene Vehicle -- Viruses Used in Gene Therapy -- Ashi Desilva: A Promising Start -- Clinical Trials Defined -- Cells of the Immune System -- Adenosine Deaminase(ADA) -- Preliminary Research -- Clinical Procedure for ADA Gene Therapy -- Jesse Gelsinger:Down To Earth: Ornithine Transcarbamylase(OTC) -- Preliminary Research -- Clinical Procedure for OTC Gene Therapy -- The Gelsinger Clinical Trial -- The Investigation -- Conclusion Remarks -- Future Prospects: Safer Vehicles -- Reduction Immune Rejection of the Vector -- Improved Risk Assessment -- Redesigning Human Anatomy and Physiology -- Ethics of Gene Therapy -- The Belmont Report -- Clinical Trials -- Physiological Enhancement -- Cosmetic Applications -- Legal Issues: Rgulatory Agencies -- The Gelsinger Legal Trial -- International Regulation -- Resource Center -- Eukaryoke Cell Primer -- Recombinant DNA primer -- The Human Genome Project -- X- Linked Severe Combined Immunodeficiency (SCID-X1) Alzheimer,s Disease(AD) -- Huntingdon's Disease(HD).
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Books
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Permanent location Current location Shelving location Date acquired Total Checkouts Full call number Barcode Date last seen Copy number Price effective from Koha item type
          WISCONSIN INTERNATIONAL UNIVERSITY COLLEGE, GHANA - MAIN LIBRARY WISCONSIN INTERNATIONAL UNIVERSITY COLLEGE, GHANA - MAIN LIBRARY nursing 12/02/2018   RB155.8P36 NURS/398/060/18 12/02/2018 1 12/02/2018 Books

If you have any concerns or questions; kindly contact the library


© Powered by WIUC IT - Support Services Unit